0001493152-18-010156.txt : 20180718 0001493152-18-010156.hdr.sgml : 20180718 20180718200513 ACCESSION NUMBER: 0001493152-18-010156 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180716 FILED AS OF DATE: 20180718 DATE AS OF CHANGE: 20180718 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bonstein Sara CENTRAL INDEX KEY: 0001604019 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-54318 FILM NUMBER: 18959339 MAIL ADDRESS: STREET 1: 305 COLLEGE ROAD EAST CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ONCOSEC MEDICAL Inc CENTRAL INDEX KEY: 0001444307 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980573252 STATE OF INCORPORATION: NV FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 5820 NANCY RIDGE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 210-7333 MAIL ADDRESS: STREET 1: 5820 NANCY RIDGE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: NetVentory Solutions, Inc. DATE OF NAME CHANGE: 20080902 4 1 ownership.xml X0306 4 2018-07-16 0 0001444307 ONCOSEC MEDICAL Inc ONCS 0001604019 Bonstein Sara 3565 GENERAL ATOMICS COURT #100 SAN DIEGO CA 92121 0 1 0 0 CFO/COO Common Stock 2018-07-16 4 A 0 625000 A 625000 D Common Stock 2018-07-16 4 F 0 135485 1.34 D 489515 D On July 16, 2018, the reporting person was awarded 625,000 RSUs pursuant to an employment inducement award. 312,500 of the RSUs vested and converted to ONCS stock on July 16, 2018, and the remaining 312,500 RSUs vest in equal quarterly installments over the next two years, such that the award will be fully vested on July 16, 2020. Each restricted stock unit (RSU) represents the contingent right to receive one share of common stock upon vesting of the unit. In connection with the vesting of 312,500 RSUs on July 16, 2018, a total of 135,485 shares were withheld by the Company from such RSUs in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such withholding, which was conducted automatically in accordance with the issuer's corporate policies. /s/ Sara M. Bonstein 2018-07-18